Institutional investors purchased a net $4.2 million shares of NVO during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 9.21% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Major industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARROWSTREET CAPITAL LP Bought 2.4 Million shares of Novo Nordisk
OPPENHEIMERFUNDS, INC. Bought 1.9 Million shares of Novo Nordisk
KCG AMERICAS LLC Bought 1.4 Million shares of Novo Nordisk